Biosimilar SB16 Matches Denosumab in Exhaustive Analytical Comparison
A comprehensive analytical characterization shows the newly approved denosumab biosimilar SB16 is highly similar to Prolia and Xgeva across structure, ...
A comprehensive analytical characterization shows the newly approved denosumab biosimilar SB16 is highly similar to Prolia and Xgeva across structure, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine